2022
DOI: 10.18332/tid/152137
|View full text |Cite
|
Sign up to set email alerts
|

Smoking trajectory and cancer risk: A population-based cohort study

Abstract: INTRODUCTION Smoking behavior can change with time and lead to different health outcomes. This study explored the trajectory of smoking and its relationship with cancer incidence and mortality among Korean male adults. METHODS We used 2002–2018 data from the National Health Insurance Service (NHIS). Smoking status was repeatedly measured in four waves of general health examinations provided by the NHIS between 2002 and 2009. Cancer incidence and mortality were tracked f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 31 publications
1
6
0
Order By: Relevance
“…Adjusting for a smoking prevalence difference of 6% and assuming RRs for smoking and lung cancer and laryngeal cancer between 7.00 and 12.00, the HR of 1.16 for lung cancer would decrease to between 1.05 and 1.06 and the HR of 1.21 for laryngeal cancer would decrease to between 1.10 and 1.11 (Supplemental file 2, Figures 2 and 3). Assuming RRs for smoking and esophageal cancer around 2.5 [27, 45], the HR of 1.27 for esophageal cancer would decrease to between 1.18 and 1.25 (Supplemental file 2, Figure 4).…”
Section: Resultsmentioning
confidence: 99%
“…Adjusting for a smoking prevalence difference of 6% and assuming RRs for smoking and lung cancer and laryngeal cancer between 7.00 and 12.00, the HR of 1.16 for lung cancer would decrease to between 1.05 and 1.06 and the HR of 1.21 for laryngeal cancer would decrease to between 1.10 and 1.11 (Supplemental file 2, Figures 2 and 3). Assuming RRs for smoking and esophageal cancer around 2.5 [27, 45], the HR of 1.27 for esophageal cancer would decrease to between 1.18 and 1.25 (Supplemental file 2, Figure 4).…”
Section: Resultsmentioning
confidence: 99%
“…Assuming a 6% difference in smoking prevalence and a range of RRs for smoking and kidney cancer between 1.25 and 1.75 [44], the observed adjusted HR for kidney cancer of 1.21 would be reduced to between 1.17 and 1.18, a change of about 3.3% (Supplemental le, Figure S2). Assuming a range of RRs for smoking and esophageal cancer between 1.5 and 3.5 [44][45], the observed adjusted HR of 1.24 would be reduced to between 1.17 and 1.21, a change of no more than 5.6% (Supplemental le, Figure S3).…”
Section: Vital Status Ascertainmentmentioning
confidence: 99%
“…Smoking cessation or reduction, particularly when done at a young age, can reduce the incidence and mortality of cancer. Men who completed four health tests in 2002-2003, 2004-2005, 2006-2007, and 2008-2009 were included in their analyses, along with all covered individuals under the national health insurance plan [ 8 ]. According to a population-based cohort study conducted by Jee et al on 430,951 people, the risk of bladder cancer did not change significantly according to the trajectory, with the exception of the low stable group.…”
Section: Reviewmentioning
confidence: 99%
“…It can also increase the risk of oral cavity problems like periodontitis [ 7 ]. Furthermore, smoking increases the risk of cancer [ 8 , 9 ]. Tobacco smoke is a complex mix of chemicals that includes many mutagens and carcinogens, such as polycyclic aromatic hydrocarbons (PAHs) and tobacco-specific nitrosamines (TSNAs), which are found in all tobacco products, including cigarettes, cigars, and smokeless tobacco.…”
Section: Introductionmentioning
confidence: 99%